Vaxcyte, Inc. (PCVX) Q4 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Vaxcyte, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:04.870 Good afternoon. My name is Lisa, and I will be your conference operator today. 00:00:04.870 -- 00:00:10.552 At this time, I would like to welcome everyone to the FACT site fourth quarter 00:00:10.552 -- 00:00:13.562 and full year 2022 00:00:13.793 -- 00:00:18.634 financial results conference call. All lines have been placed on mute to prevent any 00:00:18.634 -- 00:00:24.676 background noise. After the speaker's remarks, there will be a question and answer session. 00:00:24.676 -- 00:00:30.129 If you would like to ask a question during this time, simply press star one one. 00:00:30.129 -- 00:00:34.862 on your telephone keypad. If you would like to withdraw your question, please press star 00:00:34.862 -- 00:00:37.553 11 again. 00:00:37.915 -- 00:00:42.918 I now would like to turn the call over to Andrew Guggenheim, President and 00:00:42.918 -- 00:00:48.401 Chief Financial Officer of AXSET. Please go ahead, sir. 00:00:59.875 -- 00:01:03.096 Thank you, Operator, and good afternoon, everyone. 00:01:03.096 -- 00:01:08.499 I'd like to welcome you to VACCITE's earnings conference call to discuss our 2022 results 00:01:08.499 -- 00:01:13.721 and to provide a business update. I am joined today by our Chief Executive Officer, 00:01:13.721 -- 00:01:18.803 Grant Pickering, our EVP and Chief Operating Officer, Jim Wassel, 00:01:18.803 -- 00:01:22.265 and our VP of Research, Jeff Harriman. 00:01:22.265 -- 00:01:26.507 Earlier this afternoon, we issued a news release announcing our results. 00:01:26.507 -- 00:01:31.742 Copies of this and our other news releases latest corporate presentation, and 00:01:31.742 -- 00:01:37.865 SEC filings can be found in the Investors and Media section of our website. 00:01:38.167 -- 00:01:42.750 Before we begin, ...